Press Release

The new Bengaluru-based platform integrates mass spectrometry-driven workflows with advanced bioanalytical and clinical research capabilities to deliver regulatory‑ready data for global biopharma sponsors. Bengaluru, India | May 11, 2026 — Agilent Technologies, a global leader in analytical and laboratory solutions, today announced a strategic collaboration with Veeda Lifesciences to strengthen regulatory‑aligned analytical and bioanalytical workflows […]

Collaboration to facilitate advanced biologics testing by providing HCP coverage, characterization, and quantification assays, and related services to customers globally. New center will help improve safety, efficacy, and quality in biopharma development. Combination of Cytiva’s analytical technologies with Veeda’s extensive service delivery capabilities and regulatory expertise. November 28, 2025 The Cytiva and Veeda team, with […]

Ahmedabad, India – July 08, 2025: Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in Mango Sciences, a Boston-based healthcare AI and data company. Through this investment, Veeda intends to leverage AI capabilities to enhance the speed, efficiency, and quality of Clinical Trials services across its expanded global network, enabling more […]

Veeda Group has unveiled a new logo and brand identity—Veeda Lifesciences—marking a key milestone in its journey. The new

DUBLIN and AHMEDABAD, India, March 26, 2024 /PRNewswire/ — Veeda Clinical Research Limited, a full-service contract research organization (CRO) with a proven record of drug development success, announced that it has acquired Heads, a privately held European CRO, which specializes in conducting clinical trials in oncology. Established in 2010, Heads has an operational presence in 25 multiple strategically important locations across Europe, North America, and […]